Primary CNS Lymphoma Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Methotrexate, Tafasitamab, Lenalidomide and Rituximab in Patients With PCNSL
Condition: Non-Hodgkin Lymphoma Interventions: Drug: Tafasitamab; Drug: Lenalidomide; Drug: Rituximab; Drug: Methotrexate Sponsors: University of Cologne; Incyte Corporation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 17, 2022 Category: Research Source Type: clinical trials
Orelabrutinib,Rituximab and Methotrexate in Newly-diagnosed Primary Central Nervous System Lymphoma(PCNSL)
Condition: Primary Central Nervous System Lymphoma Intervention: Drug: Orelabrutinib,Rituximab and Methotrexate Sponsor: Affiliated Hospital to Academy of Military Medical Sciences Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 22, 2022 Category: Research Source Type: clinical trials
